Subscribe to Newsletter
Manufacture Quality & Compliance, Standards & Regulation

Beyond borders: Navigating global scale-up for viral-based therapies

sponsored by ReciBioPharm

Register here

December 13, 2023 - 11:00AM ET

Bringing viral-based therapies to market can be complex. Collaborating with a trusted partner is essential to overcoming the range of challenges associated with the journey to market. This webinar will delve into the benefits of a customer-focused approach. We will explore the intricate challenges that customers have presented to us and the collaborative strategies deployed to effectively resolve them.

The discussion will be centered on our comprehensive experiences in handling oncolytic viruses. Specifically, we will focus on the intricacies involved in the production of egg-based vaccines, followed by an illuminating presentation of data related to adeno-associated virus (AAV).

The webinar will end by highlighting the establishment of redundant pathways for the production of commercial material. This will be exemplified through the strategic positioning of facilities in both Europe and the US. We will emphasize the inherent redundancies and flexibility within infrastructure and the supply chain.

Webinar Learning Objectives:

  • Drawing upon our extensive experience in viral-based therapeutics manufacturing, we will illustrate the benefits of partnering with right CDMO partner. The essential involvement of a CDMO will provide access to the intricate processes required to produce viral-based therapeutics.
  • We will highlight the advantages and efficiencies gained from partnering with a CDMO which has the capacity to produce viral-based commercial processes in both Europe and the US. This will underline the substantial time and monetary savings afforded to clients through strategic transcontinental operations.

Register here

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related White Papers
Highly sensitive and robust LC-MS/MS solution for quantitation of nitrosamine impurities in metformin drug products

| Contributed by Thermo Fisher Scientific

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register